Evidence mapPaperPMID 35966103Full record

ArticleFrontiers in endocrinology2022

The association between a body shape index and elevated urinary albumin-creatinine ratio in Chinese community adults.

Yue Zhang, Wenxing Gao, Binqi Li, Yang Liu, Kang Chen, Anping Wang, Xulei Tang, Li Yan, Zuojie Luo, Guijun Qin and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 1 country.

Yue ZhangMedical School of Chinese People's Liberation Army, Beijing, China.
Wenxing GaoMedical School of Chinese People's Liberation Army, Beijing, China.
Binqi LiSchool of Medicine, Nankai University, Tianjin, China.
Yang LiuDepartment of Endocrinology, The First Clinical Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
Kang ChenDepartment of Endocrinology, The First Clinical Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
Anping WangDepartment of Endocrinology, The First Clinical Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
Xulei TangDepartment of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, China.
Li YanSun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
Zuojie LuoDepartment of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Guijun QinDepartment of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lulu ChenUnion Hospital, Tongji Medical College, Wuhan, China.
Qin WanDepartment of Endocrinology, Affiliated Hospital of Luzhou Medical College, Luzhou, China.
Zhengnan GaoDepartment of Endocrinology, Dalian Municipal Central Hospital, Dalian, China.
Weiqing WangRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Guang NingRuijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yiming MuDepartment of Endocrinology, The First Clinical Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
Chinese People's Liberation Army · CNChinese People’s Liberation Army 263 hospital · CNDalian Municipal Central Hospital · CNFirst Affiliated Hospital of GuangXi Medical University · CNFirst Affiliated Hospital of Sichuan Medical University · CNFirst Affiliated Hospital of Zhengzhou University · CNLanzhou University · CNNankai University · CNRuijin Hospital · CNShanghai Jiao Tong University · CNSun Yat-sen University · CNWuhan Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Obesity, especially visceral obesity, seems to be one of the most decisive risk factors for chronic kidney disease. A Body Shape Index (ABSI) is an emerging body size measurement marker of visceral obesity. This study aimed to explore whether ABSI is associated with albuminuria in Chinese community adults. Methods: This cross-sectional study enrolled 40,726 participants aged 40 or older from seven provinces across China through a cluster random sampling method. ABSI was calculated by body mass index, waist circumference, and height. Increased albuminuria was defined as urinary albumin-creatinine ratio (UACR) ≥ 30 mg/g, indicating kidney injury. For ABSI, we divided it by quartile cutoff points and tried to determine the association between ABSI levels and UACR by multiple regression analysis. DAG (Directed Acyclic Graph) was plotted using literature and expert consensus to identify potential confounding factors. Results: The average age of subjects with elevated UACR was 61.43 ± 10.07, and 26% were men. The average age of subjects with normal UACR was 57.70 ± 9.02, and 30.5% were men. Multiple logistic regression analysis was conducted and demonstrated that the ABSI quartiles were related to elevated UACR positively (OR [95% CI] Q2 vs. Q1: 1.094 [1.004, 1.197]; OR [95% CI] Q3 vs. Q1: 1.126 [1.030, 1.231]; OR [95% CI] Q4 vs. Q1: 1.183 [1.080, 1.295], Conclusions: In Chinese community adults, people with higher ABSI levels can be deemed as high-risk individuals with UACR elevation, and it will be beneficial for them to lose weight and significantly reduce visceral fat.

Indexed as

AlbuminuriaObesity, AbdominalAdultAgedAlbuminsBody Mass IndexChinaCreatinineCross-Sectional StudiesFemaleHumansMaleAlbuminsCreatininea body shape indexalbuminuriabody mass indexchronic kidney diseasevisceral obesity

Identifiers

PMID35966103
PMCPMC9365939
OpenAlexW4288074578

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.